General Biotechnology

The strength of pharmaceutical IPRs vis-à-vis foreign direct investment in clinical research: Preliminary findings

This article examines the effect of the intellectual property (IP) environment in developing countries on the level of foreign direct investment (FDI) and technology transfer occurring in the biopharmaceutical field in these countries. In particular, i…

The strength of pharmaceutical IPRs vis-à-vis foreign direct investment in clinical research: Preliminary findings Read Post »

General Biotechnology

Innovation in R&D: Using design thinking to develop new models of inventiveness, productivity and collaboration

By adapting insights and methodologies from design thinking, a modern scientific R&D organization may have the potential to increase the speed, inventiveness and vitality of their output and become an explosive engine of growth. Modern design consu…

Innovation in R&D: Using design thinking to develop new models of inventiveness, productivity and collaboration Read Post »

General Biotechnology

Innovation in R&D: Using design thinking to develop new models of inventiveness, productivity and collaboration

By adapting insights and methodologies from design thinking, a modern scientific R&D organization may have the potential to increase the speed, inventiveness and vitality of their output and become an explosive engine of growth. Modern design consu…

Innovation in R&D: Using design thinking to develop new models of inventiveness, productivity and collaboration Read Post »

General Biotechnology

Biotechnology commercialisation in universities of developing countries: A review of the University of Ibadan, Nigeria

The British colonial administration established the University of Ibadan (UI) in 1948 as an extension of the University College London and it became Nigeria’s first full-fledged and premier university in 1962. The university comprises 13 faculties and …

Biotechnology commercialisation in universities of developing countries: A review of the University of Ibadan, Nigeria Read Post »

General Biotechnology

New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?

Biotechnology companies can play an important role in advancing technologies for global health. Initiatives such as Genzyme’s Humanitarian Assistance for Neglected Diseases and Alnylam’s Intellectual Property (IP) contributions to the Pool for Open Inn…

New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health? Read Post »

Biotechblog
Scroll to Top